Vertex Sharp Waves Span Sleep Stages, Study Argues for Scoring Revision

Vertex sharp waves (VSW) — sharply contoured transients under 500 milliseconds, maximal over the central (vertex) regions — have long been treated as markers of sleep stage N1. A new study in Clinical EEG and Neuroscience (Volume 57, Issue 5, pages 442–448, September 2026) characterizes their distribution across sleep stages and argues the conventional association carries direct implications for how technologists and readers score routine polysomnograms and sleep-deprived scalp EEG.

The authors, writing under the title "Characterization of Vertex Sharp Waves: Sleep Stage Distribution Pattern and Implications for Scoring," start from the standard definition: sharply contoured waves of less than 500 milliseconds duration with a central maximum. Textbook practice ties these transients to the transition from wakefulness into N1 sleep, and many scoring workflows treat their appearance as supportive evidence for that stage border.

What does the study examine?

The investigators postulate that VSW are not confined to N1 and set out to characterize their sleep stage distribution pattern systematically. The published abstract frames the central question directly: if these central sharp transients appear across multiple stages rather than solely at sleep onset, stage scoring that leans on VSW as an N1 sign may misattribute epochs.

For the reading room, the practical stake is straightforward. Scalp EEG readers and polysomnography technologists who use vertex sharp waves as a stage-transition cue need to know whether the same waveform appears in N2, N3 or later N1 epochs — and in what proportion — before anchoring a stage call to it.

Why the distinction matters for scoring

Sleep staging under AASM-style rules depends on recognizable landmarks: K-complexes and sleep spindles for N2, slow-wave thresholds for N3, and for N1, a mixture of alpha attenuation, vertex sharp waves and slow eye movements. A waveform that crosses stage boundaries weakens its diagnostic weight as a single-stage sign.

The study's stated objective — characterizing the sleep stage distribution pattern of VSW — addresses exactly this evidentiary gap. By quantifying where these sub-500-millisecond central transients occur across the night, the authors provide data that scorers can use to weight VSW appropriately rather than as a de facto N1 signature.

This is an analysis of human sleep recordings reported in a peer-reviewed clinical neurophysiology journal, not device research and not animal work; no new hardware or FDA-cleared system is involved. The implications run through scoring manuals, reading-room conventions and technologist training rather than through instrumentation.

What does this change for the EEG lab?

For labs scoring routine polysomnography and for epileptologists reading sleep-deprived scalp EEG, the study offers a distribution-based check on a familiar heuristic. If VSW appear beyond N1 at measurable rates, epoch-by-epoch staging should rely on the fuller stage-defining ensemble — background rhythm, eye movement channels, K-complexes, spindles — with VSW treated as supportive rather than determinative.

The full stage-by-stage breakdown, methodology and quantitative results appear in the September 2026 issue of Clinical EEG and Neuroscience; readers seeking the distribution figures and the authors' specific scoring recommendations should consult the complete article.